Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perlmutter Cancer Center—34th Street is a premier outpatient oncology facility in Manhattan and a key clinical site for NYU Langone Health’s NCI-designated Comprehensive Cancer Center. The center provides multidisciplinary care for a wide range of cancers, including breast, lung, and gastrointestinal malignancies, utilizing advanced treatment modalities such as radiation therapy and infusion services. It serves as a hub for clinical research, offering patients access to innovative clinical trials and personalized medicine based on molecular profiling. The facility integrates comprehensive support services, including genetic counseling, nutrition, and social work, to enhance the patient experience. As part of the broader NYU Langone Health system, it maintains a strong focus on translating scientific discoveries into clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 34th Street Cancer Center.